Print

Purpose

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy. In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes: Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance. Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.

Conditions

Eligibility

Eligible Ages
Over 60 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

for older adults with dementia: 1. Age 60 or older 2. Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment 3. Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia) 4. Taking 3 or more medications 5. Involved with managing their medications 6. Proficient speaking English 7. Capacity to provide consent Inclusion criteria for caregivers include:: 1. Primary family caregiver for the past 3 months 2. Age 18 or older 3. Proficient speaking English

Exclusion Criteria

  • adults unable to consent

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Medication Collaboration Intervention 		Participants receive a brief virtual medication collaboration intervention designed to support collaborative medication management among older adults with early-stage dementia and their family caregivers. The intervention includes an assessment of medication responsibilities and beliefs, dementia and medication management education, reframing beliefs about autonomy and caregiver assistance, and collaborative development of medication management plans and action planning by setting implementation intentions.
  • Behavioral: Medication Collaboration Intervention
    A brief virtual behavioral intervention for older adults with early-stage dementia and their family caregivers designed to support collaborative medication management. The intervention includes: (1) assessment of beliefs about dementia, autonomy, and current medication responsibilities; (2) education on dementia progression and medication management; (3) reframing maladaptive beliefs regarding independence and caregiver assistance; and (4) collaborative development of implementation intentions and medication responsibility plans to facilitate medication adherence and the transition of medication management responsibilities. The intervention is delivered remotely via Zoom or telephone in a single 45-60-minute session by trained study interventionists.

Recruiting Locations

Northwestern University
Chicago, Illinois 60611
Contact:
Dianne Oladejo
312.503.6452
dianne.oladejo@northwestern.edu

More Details

Status
Recruiting
Sponsor
Northwestern University

Study Contact

Rachel O'Conor
13125033240
r-oconor@northwestern.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.